Application Nr Approved Date Route Status External Links
ANDA210708 None Oral None Google , Wikipedia , PubMed , DailyMed , Raw OpenFDA , ECHA , ToxNet , JECFA , FAO , 21 CFR

Indications and Purposes

1 Indications And Usage Eletriptan Hydrobromide Tablets Are Indicated For The Acute Treatment Of Migraine With Or Without Aura In Adults. Limitations Of Use: Use Only If A Clear Diagnosis Of Migraine Has Been Established. If A Patient Has No Response To The First Migraine Attack Treated With Eletriptan Hydrobromide Tablets, Reconsider The Diagnosis Of Migraine Before Eletriptan Hydrobromide Tablets Are Administered To Treat Any Subsequent Attacks. Eletriptan Hydrobromide Tablets Are Not Intended For The Prevention Of Migraine Attacks. Safety And Effectiveness Of Eletriptan Hydrobromide Tablets Have Not Been Established For Cluster Headache. Eletriptan Hydrobromide Is A Serotonin (5-Ht 1b/1d ) Receptor Agonist (triptan) Indicated For The Acute Treatment Of Migraine With Or Without Aura In Adults (1) Limitations Of Use: Use Only After A Clear Diagnosis Of Migraine Has Been Established (1) Not Indicated For The Prophylactic Therapy Of Migraine (1) Not Indicated For The Treatment Of Cluster Headache (1)

All Formulated Excipients (0 Total)

None

Active Ingredients ( 1 Total)

Name Structure ZINC ID(s)
1. Eletriptan Hydrobromide ELETRIPTAN HYDROBROMIDE ZINC3823475

Comments